|
|
||||||||
Enzymes and Protein Markers |
Departments of
1
Pathology and
2
Medical and Research Technology, University of Maryland School of Medicine, Baltimore, MD 21201.
3
Department of Laboratory Medicine and Pathology, Hennepin
County Medical Center, Minneapolis, MN 55415.
4
Clinical Pathology, University of Texas Southwestern
Medical Center, Dallas, TX 75235-9072.
5
Beckman Instruments, Inc., Chaska, MN 55318-1084.
a Address correspondence to this author at: Clinical Pathology, University of Maryland Medical Center, 22 South Greene St., Baltimore, MD 21201. Fax 410-328-5880; e-mail rchriste{at}umabnet.ab.umd.edu.
We evaluated the ACCESS® cardiac troponin I (cTnI) immunoassay as a marker for myocardial infarction (MI). Total imprecision was 6.0% to 13.5%, the minimum detectable concentration was 0.007 µg/L, and the limit of quantitation was 0.046 µg/L. Comparison of cTnI measurement between the ACCESS and Stratus systems (n = 114) showed a proportional difference: ACCESS cTnI = 0.0996 Stratus cTnI + 0.049 µg/L (r = 0.811). Fifty-nine of 61 ambulatory patients without cardiac symptoms had no detectable cTnI (95% range, 0.00 to 0.025 µg/L). The optimum cutoff for discriminating MI (n = 289, 45 with MI) was 0.15 µg/L by receiver operator characteristic curve analysis; at this cutoff, the ACCESS cTnI assay showed a sensitivity of 88.9% (95% CI, 79.798.1%) and specificity of 91.8% (95% CI, 88.495.2%). The ACCESS cTnI assay results showed 89.4% and 93.0% concordance with the MB isoenzyme of creatine kinase (CK-MB) mass and Stratus cTnI results, respectively, for classification of patients with suspected MI. The ACCESS cTnI assay appears to show sensitivity and specificity comparable with those of both CK-MB mass and Stratus cTnI assays for the diagnosis of MI in patients presenting within 12 h of onset of symptoms.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Tunca, M. Sozmen, H. Erdogan, M. Citil, E. Uzlu, H. Ozen, and E. Gokce Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease J Vet Diagn Invest, September 1, 2008; 20(5): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gunes, G. Atalan, M. Citil, and H. M. Erdogan Use of cardiac troponin kits for the qualitative determination of myocardial cell damage due to traumatic reticuloperitonitis in cattle Vet Rec., April 19, 2008; 162(16): 514 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Howell, J. P. Thompson, A. F. Nimmo, C. Snowden, N. D. Edwards, J. Carlisle, M.-S. Suleiman, and A. Baumbach Relationship between perioperative troponin elevation and other indicators of myocardial injury in vascular surgery patients Br. J. Anaesth., March 1, 2006; 96(3): 303 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bunk and M. J. Welch Characterization of a New Certified Reference Material for Human Cardiac Troponin I Clin. Chem., February 1, 2006; 52(2): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ammann, M. Pfisterer, T. Fehr, and H. Rickli Raised cardiac troponins BMJ, May 1, 2004; 328(7447): 1028 - 1029. [Full Text] [PDF] |
||||
![]() |
R. Labugger, J. A. Simpson, M. Quick, H. A. Brown, C. E. Collier, I. Neverova, and J. E. Van Eyk Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry Clin. Chem., June 1, 2003; 49(6): 873 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sandri, D. Cardinale, L. Zorzino, R. Passerini, P. Lentati, A. Martinoni, G. Martinelli, and C. M. Cipolla Minor Increases in Plasma Troponin I Predict Decreased Left Ventricular Ejection Fraction after High-Dose Chemotherapy Clin. Chem., February 1, 2003; 49(2): 248 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Fransen, J. H. C. Diris, J. G. Maessen, W. Th. Hermens, and M. P. van Dieijen-Visser Evaluation of "New" Cardiac Markers for Ruling Out Myocardial Infarction After Coronary Artery Bypass Grafting Chest, October 1, 2002; 122(4): 1316 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Panteghini Performance of Today's Cardiac Troponin Assays and Tomorrow's Clin. Chem., June 1, 2002; 48(6): 809 - 810. [Full Text] [PDF] |
||||
![]() |
N.J. Alp, J.A. Bell, and M. Shahi A rapid troponin-I-based protocol for assessing acute chest pain QJM, December 1, 2001; 94(12): 687 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe Testing the wrong hypothesis: the failure to recognize the limitations of troponin assays J. Am. Coll. Cardiol., October 1, 2001; 38(4): 999 - 1001. [Full Text] [PDF] |
||||
![]() |
J. C.J.M. Swaanenburg, B. G. Loef, M. Volmer, P. W. Boonstra, J. G. Grandjean, M. A. Mariani, and A. H. Epema Creatine Kinase MB, Troponin I, and Troponin T Release Patterns after Coronary Artery Bypass Grafting with or without Cardiopulmonary Bypass and after Aortic and Mitral Valve Surgery Clin. Chem., March 1, 2001; 47(3): 584 - 587. [Full Text] [PDF] |
||||
![]() |
C. W. Hamm and E. Braunwald A Classification of Unstable Angina Revisited Circulation, July 4, 2000; 102(1): 118 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heeschen, B. U. Goldmann, L. Langenbrink, G. Matschuck, and C. W. Hamm Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest Pain Clin. Chem., October 1, 1999; 45(10): 1789 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hurst, M. Hinrichs, C. Breidenbach, N. Katz, and B. Waldecker Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators J. Am. Coll. Cardiol., August 1, 1999; 34(2): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, M. Y. Zhang, Q. Song, X. Zhang, L. Kadijevic, and Q. Shi Extra Leader Sequence Affects Immunoactivity of Cardiac Troponin I Clin. Chem., August 1, 1999; 45(8): 1300 - 1302. [Full Text] [PDF] |
||||
![]() |
Q. Shi, M. Ling, X. Zhang, M. Zhang, L. Kadijevic, S. Liu, and J. P. Laurino Degradation of Cardiac Troponin I in Serum Complicates Comparisons of Cardiac Troponin I Assays Clin. Chem., July 1, 1999; 45(7): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, R. H. Christenson, R. Valdes Jr., A. J. Andriak, A. Berg, S.-H. Duh, Y.-J. Feng, S. A. Jortani, N. A. Johnson, B. Koplen, et al. Simultaneous Rapid Measurement of Whole Blood Myoglobin, Creatine Kinase MB, and Cardiac Troponin I by the Triage Cardiac Panel for Detection of Myocardial Infarction Clin. Chem., February 1, 1999; 45(2): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, A. J. Maturen, R. E. Mullins, P. C. Painter, M. S. Pessin-Minsley, R. A. Webster, J. Spray Flores, R. DeCresce, D. J. Fink, P. M. Buckley, et al. Multicenter Clinical and Analytical Evaluation of the AxSYM Troponin-I Immunoassay to Assist in the Diagnosis of Myocardial Infarction Clin. Chem., February 1, 1999; 45(2): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hetland and K. Dickstein Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting Clin. Chem., July 1, 1998; 44(7): 1430 - 1436. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |